![MGTA-456, a first-in-class cell therapy that enables a reduced intensity conditioning regimen and enhances speed and level of human microglia engraftment in the brains of NSG mice]()
MGTA-456, a first-in-class cell therapy that enables a reduced intensity conditioning regimen and enhances speed and level of human microglia engraftment in the brains of NSG miceGoncalves, Kevin A.; Li, Shuping; Brooks, Melissa L.; Hyzy, Sharon L.; Boitano, Anthony E.; Cooke, Michael P. · Molecular Genetics and Metabolism · 2019